Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα

Abstract

The NF-κB/Rel family of transcription factors regulates a wide variety of genes whose products play a fundamental role in inflammatory and immune responses. The implication of NF-κB/Rel proteins and their IκB regulatory subunits in the control of cellular growth and oncogenesis, was suggested by the induction of fatal lymphomas in birds by the v-rel oncoprotein, and the rearrangement and amplification of several genes encoding the NF-κB/Rel/IκB signal transduction factors in human malignancies, primarily of lymphoid origin. Hodgkin's disease (HD) is a lymphoma characterized by a low frequency of malignant Hodgkin and Reed – Sternberg (H/RS) cells in a reactive background of non-neoplastic cells. The peculiar activated phenotype of Hodgkin and Reed – Sternberg cells and their pattern of cytokine secretion are believed to be a consequence of constitutive activation of the NF-κB transcription factor. Here, we report the detection of mutations of the IkBa gene, in two HD-derived cell lines and in two out of eight biopsy samples from patients with relapsed Hodgkin's disease. The presence of defective IκBα is thus likely to explain the constitutive activation of NF-κB in these cells and suggests that IκBα is a tumour suppressor controlling the oncogenic activation of NF-κB in Hodgkin and Reed – Sternberg cells.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Arenzana-Seisdedos F, Thompson J, Rodriguez M, Bachelerie F, Thomas D and Hay RT. . 1995 Mol. Cell. Biol. 15: 2689–2696.

  • Baeuerle PA and Baltimore D. . 1996 Cell 87: 13–20.

  • Baldwin Jr AS. . 1996 Annu. Rev. Immunol. 14: 649–683.

  • Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K, Royer H-D, Scheidereit C and Dörken B. . 1996 Blood 87: 4340–4347.

  • Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer H-D, Grinstein E, Greiner A, Scheidereit C and Dörken B. . 1997 J. Clin. Invest. 100: 2961–2969.

  • Beauparlant P, Kwan I, Bitar R, Chou P, Koromilas AE, Sonenberg N and Hiscott J. . 1994 Oncogene 9: 3189–3197.

  • Beg AA, Sha WC, Bronson RT and Baltimore D. . 1995 Genes Dev. 9: 2736–2746.

  • Chiao PJ, Miyamoto S and Verma IM. . 1994 Proc. Natl. Acad. Sci. USA. 91: 28–32.

  • DeMartin R, Vanhove B, Cheng Q, Hofer E, Csizmadia V, Winkler H and Bach FH. . 1993 EMBO J. 12: 2773–2779.

  • Diehl V. . 1996 Baillieres Clin. Haematol. 9, Preface to Hodgkin's disease.

  • Drexler H-G. . 1993 Leukemia Lymphoma 9: 1–25.

  • Gilmore TD, White DW, Sarkar S and Sif S. . 1995 In: The DNA provirus: Howard Temin's Scientific Legacy. Cooper GM, Greenberg Temin R and Sugden B. (eds).. ASM Press: Washington DC pp. 109–128.

    Google Scholar 

  • Gilmore TD, Koedood M, Piffat KA and White DW. . 1996 Oncogene 13: 1367–1378.

  • Gruss H-J and Herrmann F. . 1996 Leukemia Lymphoma 20: 397–409.

  • Gruss H-J and Kadin ME. . 1996 Baillieres Clin. Haematol. 9: 417–446.

  • Gruss H-J, Brach MA, Drexler H-G, Bonifer R, Mertelsmann RH and Herrmann F. . 1992 Cancer Res. 52: 3353–3360.

  • Gruss H-J, Pinto A, Duyster J, Poppema S and Herrmann F. . 1997 Immunology today 18: 156–163.

  • Haskill S, Beg AA, Tompkins SM, Morris JS, Yurochko AD, Sampson-Johannes A, Mondal K, Ralph P and Baldwin Jr AS. . 1991 Cell 65: 1281–1289.

  • Hirano F, Chung M, Tanaka H, Maruyama N, Makino I, Moore DD and Scheidereit C. . 1998 Mol. Cell. Biol. 18: 2596–2607.

  • Ito CY, Adey N, Bautch VL and Baldwin Jr AS. . 1995 Genomics 29: 490–495.

  • Jaffray E, Wood KM and Hay RT. . 1995 Mol. Cell. Biol. 15: 2166–2172.

  • Jung M, Zhang Y, Lee S and Dritschilo A. . 1995 Science 268: 1619–1621.

  • Karin M and Delhase M. . 1998 Proc. Natl. Acad. Sci. USA 95: 9067–9069.

  • Kitajima I, Shinohara T, Bilakovics J, Brown DA, Xu X and Nereneberg M. . 1992 Science 258: 1792–1795.

  • Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt H, Chen C-H, Rosen CA and Stewart CL. . 1996 Mol. Cell. Biol. 16: 2341–2349.

  • Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Dörken B and Scheidereit C. . 1999 Oncogene 18: 943–953.

  • LeBail O, Schmidt-Ullrich R and Israël A. . 1993 EMBO J. 12: 5043–5049.

  • Lin L, DeMartino GN and Greene WC. . 1998 Cell 92: 819–828.

  • Luque I and Gelinas C. . 1997 Sem. Cancer Biol. 8: 103–111.

  • Mosialos G. . 1997 Sem. Cancer Biol. 8: 121–129.

  • Sonenshein GE. . 1997 Sem. Cancer Biol. 8: 113–119.

  • Stancovski I and Baltimore D. . 1997 Cell 91: 299–302.

  • Sylla BS, Hung SC, Davidson DM, Hatzivassiliou E, Malinin NL, Wallach D, Gilmore TD, Kieff E and Mosialos G. . 1998 Proc. Natl. Acad. Sci. USA 95: 10106–10111.

  • Troelstra C, Hesen W, Bootsma D and Hoeijmakers JHJ. . 1993 Nucl. Acids Res. 21: 419–426.

  • Verma IM and Stevenson J. . 1997 Proc. Natl. Acad. Sci. USA 94: 11758–11760.

  • Whiteside ST and Israël A. . 1997 Sem. Cancer Biol. 8: 75–82.

  • Wood KM, Roff M and Hay RT. . 1998 Oncogene 16: 2131–2139.

Download references

Acknowledgements

We are indebted to Alex Houston (University of St Andrews) for DNA sequencing. Thanks are due to Katrina Wood (University of Newcastle, UK) and Fernando Arenzana-Seisdedos (Institut Pasteur, Paris) for providing us with L-540 and L-591 cells and rat GAPDH cDNA respectively. This work was supported by the Cunningham Trust, the Leukaemia Research Fund, the Association for International Cancer Research and the EU.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cabannes, E., Khan, G., Aillet, F. et al. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα. Oncogene 18, 3063–3070 (1999). https://doi.org/10.1038/sj.onc.1202893

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202893

Keywords

Search

Quick links